Skip to main content
PLOS One logoLink to PLOS One
. 2022 Sep 23;17(9):e0275086. doi: 10.1371/journal.pone.0275086

Time to non-adherence to iron and folic acid supplementation and associated factors among pregnant women in Hosanna town, South Ethiopia: Cox-proportional hazard model

Belay Bancha 1,*, Bereket Abrham Lajore 2, Legese Petros 1, Habtamu Hassen 1, Admasu Jemal 3
Editor: Linglin Xie4
PMCID: PMC9506621  PMID: 36149913

Abstract

Backgrounds

Micronutrient deficits in women of reproductive age have been linked to poor pregnancy outcomes. The most common micronutrient deficits in women are iron and folate. The World Health Organization recommends daily oral iron and folic acid supplementation (IFAS) as part of routine antenatal care to lower the risk of maternal anemia and adverse pregnancy outcomes. However, the effectiveness of the supplementation relies on client’s strict adherence. The aim of this study was to determine time- to- non-adherence to IFAS and associated factors among pregnant women in Hosanna Town, South Ethiopia.

Methods

A community based cross sectional study design was employed from May 15-June11, 2021. Data were entered into Epi-Data version 3.1 and exported to SPSS version 23 for analysis. The Cox regression hazard model was applied. The threshold of statistical significance was declared at a p-value <0.05 and adjusted hazard ratios (AHRs) with corresponding 95% confidence intervals were used to report.

Result

The median time-to-non-adherence was 74 days (95 percent CI: 65.33–82.67). After adjusting for the confounders, age (AHR = 1.05, 95% CI: 1.01–1.09), education status (AHR = 2.43 95%CI 1.34–4.40, AHR 3.00, 95% CI: 2.09–4.31, AHR 1.91, 95% CI: 1.32–2.77), household’s wealth index (AHR = 1.73, 95% CI: 1.19–2.51, AHR = 1.64, 95% CI:1.15–2.35), and counseling at service delivery (AHR = 2.53, 95% CI: 1.88–3.41) were independent predictors of time to non-adherence to IFAS among pregnant women.

Conclusion

The median time to non-adherence was short and women became non-adherent before the recommended duration. Improving women’s education and counseling pregnant women on IFAS during pregnancy would make a change.

Introduction

Micronutrient (MN) deficits in women of reproductive age have been linked to poor pregnancy outcomes and offspring growth and development. The most common MN deficits in women are iron and folate. Iron deficiency is well documented to have negative effects on productivity and cognition in general population, and it is the major cause of anemia during pregnancy, accounting for 20% of all maternal and perinatal death, as well as low birth weight. Folate deficiency during pregnancy can result in neural tube defects in newborns and other adverse pregnancy outcomes. Supplementation of the two MNs is frequently suggested for pregnant mothers since both forms of nutritional deficits can be prevented and treated [14].

To lower the risk of low birth weight, maternal anemia, and adverse pregnancy outcomes, the World Health Organization (WHO) highly recommends daily oral iron and folic acid supplementation (IFAS) as part of routine antenatal care. According to the guidelines, all pregnant women in all settings should receive 30–60 mg of elemental iron and 400 µg (0.4 mg) folic acid during pregnancy, starting as soon as feasible as part of standard antenatal care [57].

In accordance with WHO’s recommendations, the routine antenatal care (ANC) program of the Ethiopian Government suggested daily IFAS during pregnancy as early as feasible for a healthy pregnancy outcome [8]. The effectiveness of IFAS relies on client’s strict adherence [911], which is defined as when pregnant women attending prenatal clinics used IFA pills for at least 4 days per week prior to the survey date [12] or for > 90 days at third trimester of pregnancy [13].

Despite proved benefits [3, 14] and established international and national guidelines, evidences show that pregnant women are non-adherent to IFAS both in rural and urban settings [14, 15]. Previous research, however, did not show the time to non-adherence (time to event). Therefore, this study was aimed to generate evidence on median time to non-adherence to IFAS and associated factors among pregnant women.

Materials and methods

Setting

The research was carried out in Hosanna Town, Southern Nations Nationalities and People Regional State (SNNPR) of Ethiopia. The town is situated in 230 kilometers to the south of national capital, Addis Ababa. According to 2007 census [16], total population of the town was 69,957; 35, 503 were males and 34, 454 were females. In the same census, the population growth rate in the region was 2.9% per year. Based on this, the projected total population of the Town for 2021 was 104,387. In the region, 23.3% and 3.5% population are women in their reproductive age and expected to be pregnant respectively [17]. Based on these evidences, there were 24,323 women of reproductive age (15–49 years) and 3,654 estimated pregnancies for year 2021.

Study design and population

The research involving community based cross sectional study design was employed between May 15 and June 11, 2021. The source population consisted of all pregnant women in the research area and all pregnant women in selected sub-cities were sample population. The inclusion criteria considered all pregnant women in the study cluster who were booked for ANC one-week preceding the study. Pregnant women who were booked for ANC but whose registration for follow-up was less than one week prior the survey date were excluded. Also women who unable to recall their last normal menstrual cycle or gestational age (GA) at the time of booking were not allowed participating.

Sample size determination and sampling technique

The sample size was calculated with Epi Info version 7 using the double population proportion formula to detect a non-adherence rate of at least 25.1%, [14], 95% significance level and 5% margin of error; a sample size of 289 was obtained. The Cox proportional hazards model (power cox) was used to determine sample size for factors associated with non-adherence to IFAS using Stata version 15.0 considering the presence of censoring and adjusting for others. Non- adherence was considered a failure (outcome). Factors obtained from literatures having a significant association with adherence to IFAS were considered for sample size calculation; knowledge about IFAS [6], counseling on IFAS [12], Partner support [18], and Educational status [19]. After computing various factors, sample size calculated for educational status was 139; the largest sample size computed for factors associated with IFAS adherence. Therefore, the minimum sample size required for the non-adherence estimation would be 289. Considering 5% non-response rate [14, 20, 21] and design effect of 1.5, the final sample size was (289* +5%) *1.5 = 456.

n=(zα/2)2×p(1p)d2=(zα2)2×0.251(10.251)(0.05)2
=(1.96)2×0.1880.0025=289

Where n is required sample size, zα/2 is 95% CI, p is population proportion and d is margin of error.

Study clusters were identified using a two-stage cluster sampling procedure. After randomly selecting five Kebeles (the smallest administrative structure), total number of predefined distinct clusters (Mender) (smallest cluster within an administrative Kebele) were obtained, after which we obtained the size of the pregnant women for each cluster. The required number of clusters from each Kebele were assigned using probability proportional to population size approach, in which larger settlements have a higher chance of being selected as clusters. Reserve clusters were used until we obtain required sample size (Fig 1).

Fig 1. Diagrammatic representation of sampling technique, Hosanna town, 2021.

Fig 1

Data collection tool and procedure

Ethiopian Demographic and Health Survey 2016 (EDHS,2016) [22] and relevant literature [6, 11, 14, 18, 23] were used to adapt data collection tool.

A household’s wealth status was computed based on 23 household assets and housing quality variables which were adapted from EDHS2016 [22], given that the study setup is urban. First, all the study participants were asked about the ownership of assets by their respective households. Those who owned the asset received a score of "1," while those who did not received a score of "0". A structured questionnaire was prepared in English, translated to Amharic, and then back translated into English to ensure consistency in order to measure the required parameters. The Amharic version tool was then employed.

Operational definitions

Non-adherence

When a pregnant woman visiting an antenatal clinic took IFA tablets for less than four days per week for the week prior to the survey or for less than 90 days during the third trimester of pregnancy [12, 13].

Censored

Pregnant women who were adherent at the time of data collection were censored observations.

Event

When a pregnant lady took IFAS tablet for less than four days one week preceding the survey date, the event occurred.

Length of stay

Is the amount of days a pregnant woman contributed while on IFAS until she experienced an event of interest (non-adherent) or censorship.

Study variables

The dependent variable was time to non- adherence of IFA supplementation measured in days. Censored observations were denoted by 0, whereas events were indicated by 1. The period of time a pregnant woman spent on IFAS in days was determined as the difference between the entire GA (from LNMP to the day of data collection) and the calculated and/or reported GA at initial booking for ANC. Maternal age and educational status, household’s wealth index, counseling status of health institution on IFAS, knowledge on IFAS, waiting time to receive care, frequency of ANC visit, history of adverse fetal outcomes and history of anemia were variables hypothesized to be independent predictors of time to non-adherence which is a primary outcome in this study.

Data quality assurance

To ensure data quality, ten data collectors and one supervisor received two days training on tool clarity and overall data collection processes. The training was emphasized on sociodemographic information’s, household’s wealth status, obstetric factors, Personal exposure to media, health facility related factors, and Knowledge on IFAS and anemia. Structured questionnaire was prepared in English, translated into Amharic, and then back translated into English to ensure consistency. A pre-test was conducted on 5% of the sample size in a nearby town. Cronbach’s alpha was done to assess internal consistency (alpha coefficient for household wealth status (23 items) = 0.85, media access (3 items) = 0.71, counseling at health facility (7 items) = 0.76, Knowledge on IFAS (15 items) = 0.79). A public health officer supervised the data collection process, while the primary investigators (PIs) supervised the whole technique. All collected data were handled to PIs and checked and cleaned for consistency and completeness; daily discussion was held in case of inconsistencies.

Data processing and analysis

Epi-Data version 3.1 for data entry and Statistical Package for Social Science (SPSS) version 23 for analysis were use. Before analysis missing value, new categories and normality for continuous variables were checked. Households wealth index was computed by principal component analysis (PCA) based on household assets and housing quality variables which adapted from EDHS 2016 [22]. Pregnant women’s knowledge on IFAS was computed after performing PCA based on 15 items. Problematic variables were removed step by step, eleven items having four component factors that explains a total variance of 64.3% were retained; whose alpha coefficient was 0.78, all having acceptable correlation matrix (KMO = 0.78, x2 = 1048, P <0.001), sampling adequacy of each item was > 0.5. The value of retained variables was aggregated and used median as a cut off to declare knowledge status of study population.

The difference between total GA (spanning from last normal menstrual cycle to date of data collection) and the calculated and or reported GA at first booking for ANC was taken as total time contributed in days during which a pregnant woman was on IFAS. Survival curve was used to display the survival status (time to non-adherence) among different characteristics.

For survival analysis, the outcome variable was dichotomized to event and censored. The assumptions of proportional hazard were tested statistically and graphically. Against each categorical variable, we performed the log-og survival plot and the Kaplan-Meier survival plot. Both log-log survival plot and Kaplan-Meier survival and predicted plot revealed that the plots were parallel to each other. We have also conducted Schoenfeld test with the corresponding p-value for all variables. The Kaplan-Meier test was used to assess the median survival time between groups. The multivariate Cox Proportional Hazard model was used to examine the factors associated with time to non-adherence. The crude and adjusted hazards ratios with a 95% confidence interval (CI) were used as a measure of effect size. The Cox proportional hazard model assumption was tested graphically using log-minus-log survival plots against time for predictors. Multivariable Cox proportional hazard regression model was used to control the confounding effect of variables. In bivariate analysis, variables having a p-value < 0.25 were selected as potential predictors and used in multivariable analysis. A p-value < 0.05 with a corresponding 95% CI was declared statistically significant.

Ethics approval and consent to participate

The study was approved by the Institutional Review Board (IRB) of Hosanna Health Science College. In addition, permission was obtained from health department of the local government offices. Informed written consent was obtained from all participants. Respondents were informed that they had the right to refuse or discontinue the interview. The information provided by each respondent was kept confidential. Women who were non-adherent at the time of data collection were successfully counseled on the benefits of IFAS.

Results

Socio-demographic characteristics

The study comprised a total of 426 pregnant women, with a 93.4% response rate. The mean (± SD) age of pregnant women was 28.64 (± 4.5). In this study, almost all pregnant women (98.8%) were married, and 405 (95%) have attended formal education, 202 (47.4%), 156 (36.6%), 39 (9.2%) and 29 (6.8%) were housewives, employee, merchant and others respectively. Among the study population, 71.8% of all participants were followers of Protestant Christianity by religion and 70.9% were Hadiya ethnic. Nearly half 193 (45.3%) of household were composed of 5 or more family size. Participants’ household wealth index status was ranked; the highest, middle and the lowest tertiles, respectively, were represented by 123 (28.9%), 145 (34%) and 158 (37.1%) wealth index score (Table 1).

Table 1. Socio-demographic characteristics of pregnant women in Hosanna town, 2021 (n = 426).

Variables Category Frequency %
Marital status Married 421 98.8
Single 3 0.7
Divorced 2 0.5
Religion Protestant 306 71.8
Orthodox 87 20.4
Muslim 14 3.3
Catholic 16 3.8
Others 3 0.7
Ethnicity Hadiya 302 70.9
Kembata 51 12
Siltie 21 4.9
Amahara 33 7.7
Others 19 4.5
Educational status No formal education 21 4.9
Primary (Grade1-8) 119 27.9
Secondary (Grade 9–12) 124 29.1
Graduate 162 38
Occupation Gov’t employee 105 24.6
NGO 14 3.3
Hired in private sector 37 8.7
Merchant 39 9.2
Housewife 202 47.4
Daily laborers 15 3.5
Other 14 3.3
Household’s family size <5 233 54.7
≥5 193 45.3
HH Wealth Index Highest 123 28.9
Middle 145 34
Lowest 158 37.1

Pregnancy related conditions

In this study, 63 (14.8%) of the current pregnancy was not planned. The study also showed that only 44 (10.3%) of pregnant women booked for ANC in recommended beforehand sixteen weeks of GA. The median GA at first ANC booking was 20 weeks. Public Health institutions were predominant for ANC preference. This study documented that about eight in ten (78.4%) study participants ever skipped iron folic acid supplementation for various reasons. The most common reported reason for skipping was gastric irritation (56.3%) followed by forgetfulness (51.2%). This study revealed that 85 (20%) mothers get pregnant for the first time; so far 340 (79.8%) mothers gave birth to at least one live birth. In the current study, participants reported that 10.6%, 3.5%, 3.3% and 1.9% had history of abortion, still birth, low birth weight and preterm birth respectively. The reported prevalence of anemia in the current pregnancy among participant women accounts for 26.5%.

Personal characteristics in relation to information access

In this study women’s access to information was assessed and less than one in three watch televised media, listen to radio and read medical magazine at least once on a weekly frequency (Table 2).

Table 2. Pregnant women’s access to information in Hosanna town, 2021 (n = 426).

Access to information Not at all Less than once At least once
Weekly frequency of watching TV medical advice 146 (34.3%) 155 (36.4%) 125 (29.3%)
Weekly frequency of listening to radio 178 (41.8%) 117(27.5%) 131(30.8%)
Weekly frequency of reading medical magazine 226 (53.1%) 92(21.6%) 108(25.4%)

Counseling status and client’s knowledge on IFAS

Counseling status in health delivery system was assessed using seven items and in half of the cases counseling at service delivery was labeled as poor. The median waiting time to obtain ANC service was found to be 40 minutes. Participants knowledge status on IFAS was labeled as poor and good in 252 (59.2%) and 174 (40.8%) cases respectively.

Survival analysis

In this study, 426 pregnant women participated; contributed for 23,367 maternal-days of observations. From a total, 226 (53.1%) were non-adherent and the rest 200 (46.9%) were censored. The overall incidence of non-adherence was 10 per 1,000 maternal-days of IFAS use (95% CI: 8.8, 16.6). The Kaplan-Meier survival curve estimate shows the survival probabilities of the maternal IFAS use and the median time to non-adherence was 74 days (95% CI: 65.33–82.67).

The log-rank test results showed that the survival curve of IFAS time to non-adherence had statistically significantly difference by women’s educational status (χ2 for log-rank test = 65.63, P<0.001) (Fig 2). Based on Kaplan’s Meier survival estimate, the lower the households’ wealth index, the higher the risk of non -adherence of women to IFAS service and the difference was statistically significant between the groups (χ2 for log-rank test = 19.14, P< 0.001). Meanwhile, time to non-adherence of IFAS had statistically significantly difference by counseling status of health institutions (χ2 for log-rank test = 58.83, P<0.001).

Fig 2. Kaplan-Meier survival estimate of educational status of women taking IFAS in Hosanna town, South Ethiopia, 2021.

Fig 2

Predictors of time to non-adherence to IFAS

For factors identified as significant (p < 0.25) in the bivariable Cox regression, multivariable Cox regression analysis was performed by adjusting for confounding effects of others through stepwise backward multivariable Cox regression method. Age, education status, households’ wealth index and counseling status on service delivery were found to be independent predictors of time to non-adherence of IFAS. For one year increase in age the risk of non-adherence increases by 5% (AHR = 1.05, 95% CI: 1.01–1.08). The educational status of pregnant women was significantly associated with time to non-adherence of IFAS. Pregnant women with education level having no formal education (AHR = 2.43, 95% CI 1.34–4.40), Primary education (AHR 3.00 95% CI: 2.09–4.31) and secondary, (AHR = 1.91 95% CI 1.32–2.77) are at increased risk of early non adherence when compared to their counterpart with tertiary level education. Likewise, pregnant women in middle (AHR = 1.73, 95% CI = 1.19–2.51) and lowest (AHR = 1.64, 95% CI = 1.15–2.35) wealth tertiles status are more likely to be early non-adherent when compared to pregnant women in highest wealth class. This study also witnessed that poor counseling during service delivery at health institutions increased the hazard of non-adherence to IFAS by more than 2.5 folds (AHR = 2.53, 95% CI: 1.88–3.41) (Table 3).

Table 3. Predictors of time to non-adherence of IFAS among pregnant women in Hosanna town, South Ethiopia, 2021 (n = 426).

Variables Survival status Total CHR (95% CI) AHR (95%CI)
Event Censored
Age 226 200 426 1.04 (1.012–1.071)* 1.05 (1.02–1.08) *
Education status No formal education 16 5 21 4.24 (2.4–7.5)** 2.43 (1.34–4.4)*
Primary (Grade 1–8) 87 32 119 3.72 (2.61–5.31)** 3.00 (2.09–4.31)**
Secondary (Grade 9–12) 75 49 124 2.18 (1.51–3.14)** 1.91 (1.32–2.77)*
Graduate 48 114 162 1 1
Family Size Less than 5 126 107 233 0.81 (0.62–1.05)
Five or more 100 93 193 1
Households wealth status Highest 50 73 123 1 1
Middle 77 68 145 1.602 (1.12–2.29)* 1.73 (1.19–2.51)*
Lowest 99 59 158 2.11 (1.5–2.97)** 1.64 (1.15–2.35)*
Current pregnancy planned Yes 183 180 363 1
No 43 20 63 1.86 (1.33–2.6)**
Reported anemia in current pregnancy Yes 75 38 113 1
No 151 162 313 1.40 (1.06–1.85)*
Counseling during Service delivery Poor 154 61 215 2.91 (2.18–3.88)** 2.53 (1.88–3.41)**
Good 72 139 211 1 1
Waiting time to receive service ≤ 30 minutes 71 90 161 1
> 30 minutes 155 110 265 1.24 (0.94–1.65)
Weekly Frequency of on TV medical advice Not at all 107 39 146 2.07 (1.49–2.87)**
Less than once 65 90 155 1.02 (0.71–1.45)
At least once 54 71 125 1
Knowledge on IFAS Poor 159 93 252 2.13 (1.59–2.85)**
Good 67 107 174 1

*= p-value <0.05,

** = p-value<0.01.

Discussion

Despite its well documented benefit [7, 24, 25], this study revealed that over half of (53.1%) pregnant women in the study area were non-adherent to IFAS with the median time to non-adherence was 74 days. The early non adherence coupled with late initiation of IFAS might determine the poor pregnancy outcomes.

This study showed that for a year increase in age, there is 5% increased risk of early non adherence. This is consistent with evidences that advanced maternal age is associated with non-adherence to IFAS [3, 20, 26], indicated that women in the early reproductive ages give due attention to health care advice and as the age and the number of pregnancy increases, women become negligent; consequently become non-adherent to the supplementation during pregnancy. In our context this can be explained by the same statement that increase in age is associated with the risk of non-adherence to the supplementation. However, other studies [2729] indicated that increase in age is positively associated with IFAS compliance. This variation could be due to socio-cultural difference of the study setup. Using tertiary educational status as a reference, there is increased hazard of early non adherence among women with no formal education, primary education and secondary education. This is in line with findings from studies [3, 19] in which educational status is associated with IFAS compliance. Additionally, this is in line with a study done in Tanzania [30], that indicated educated women are more likely than their counterparts to be knowledgeable and take advantage of utilizing the supplementation during pregnancy.

The possible explanation is that literacy status could determine understanding of information, independence, self-confidence and decisions power [31], which in turn could affect adherence to medical instructions [32].

In agreement with studies in Pakistan [3], Tanzania [15] and Ethiopia [4], this study revealed that there is increased hazard of non-adherence to IFAS among women from bottom and middle wealth tertiles compared to their counterpart women from upper wealth class. Socioeconomic status (SES) is a factor that may have an impact on adherence to health behavior. This is in line with evidence [33], suggesting that lower SES may contribute to poor adherence to health recommendations by influencing individuals’ lifestyle, personal health behaviors, and access to health information. Additionally, the rationale for this might rely on the effect of cost charged for transportation for subsequent ANC visits [31]. Therefore, indirect costs might increase the hazard of non-adherence to IFAS among underprivileged wealth tertiles.

Counseling status during service delivery in health institutions was significantly associated with the hazard of non-adherence to IFAS among pregnant women. This is in line with a study in India [9] indicated that inadequate counseling is a barrier for IFAs compliance and in Tanzania [15] counseling is significantly associated with IFAS compliance. A study in Ethiopia [14] discussed that poor counseling during supplementation could adversely affect the IFAS utilization. This might be explained by the likelihood that appropriate IFAS counseling could enhance knowledge of the purpose, relevance, potential side effects, duration, and dosage of the supplement, which might subsequently have an effect on the client’s adherence to the supplement.

However, in the adjusted model, women’s IFAS knowledge does not show statistically significant difference of hazard in time to non-adherence. This could be due to the condition that knowledge is embedded in the educational status which showed significant difference of hazard on time to non-adherence. Moreover, the status of pregnancy plan in the current pregnancy, history of adverse fetal outcomes, history of anemia and frequency of ANC visit [4, 21] do not confer additional benefit in avoiding the hazard of time to non-adherence of IFAS among pregnant women.

Conclusion

The median time to non-adherence was short and women became non-adherent before the recommended duration. Pregnancy plan has no evidence of better IFAS utilization. With better educational status and counseling, the median time to non-adherence would be extended to gain optimal benefit from iron folate supplementation. Educating pregnant women on the benefit of IFAS throughout the pregnancy would make a change.

Strength and limitations

To the best of our knowledge, the current study is the first to determine time to non-adherence of IFAS. The current study revealed median time that pregnant women turning to non-adherent in the course of IFAS intake during pregnancy. Despite the significant contribution, this research has limitations. We could have not avoided the flat slop syndrome that might have inflated the censored cases. The use of one-week intake to measure the event may not reveal the reality.

Supporting information

S1 Data. Data collection tool.

(DOCX)

S2 Data. SPSS data set.

(SAV)

Acknowledgments

It is our sincere pleasure to acknowledge Institutional Review Board (IRB) of Hosanna Health Science College for thoroughly reviewing this work. We are gratitude to acknowledge all study participants, data collectors and supervisors for their contribution towards the accomplishment of this paper.

Abbreviations /acronyms

AHR

Adjusted Hazards Ratios

ANC

Antenatal Care

CHR

Crude Hazards Ratios

GA

Gestational Age

IFAS

Iron Folic Acid Supplementations

LNMP

Last Normal Menstrual Period

MN

Micronutrients

PCA

Principal Component Analysis

WHO

World Health Organizations

CI

Confidence Interval

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work

References

  • 1.Harika R, Faber M, Samuel F, Kimiywe J, Mulugeta A. Micronutrient Status and Dietary Intake of Iron, Vitamin A, Iodine, Folate and Zinc in Women of Reproductive Age and Pregnant Women in Ethiopia, Kenya, Nigeria and South Africa : A Systematic Review of Data from 2005 to 2015. 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Omolo J, Wanzala P, Lindan C, Makokha A. Utilization of Folic Acid and Iron Supplementation Services by Pregnant Women Attending an Antenatal Clinic at a Regional Referral Hospital in Kenya. Matern Child Nutr. 2013;17:1236–42. [DOI] [PubMed] [Google Scholar]
  • 3.Bin Nisar Y, Dibley MJ, Mir AM. Factors associated with non-use of antenatal iron and folic acid supplements among Pakistani women : a cross sectional household survey. BMC Pregnancy Childbirth. 2014;14(305):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sendeku FW, Azeze GG, Fenta SL. Adherence to iron-folic acid supplementation among pregnant women in Ethiopia : a systematic review and meta- analysis. BMC Pregnancy Childbirth. 2020;20(138):1–9. doi: 10.1186/s12884-020-2835-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.WHO. Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva, World Health Organization [Internet]. 2012. Available from: http://apps.who.int/iris/bitstream/10665/77770/1/9789241501996_eng.pdf. [PubMed] [Google Scholar]
  • 6.Assefa H, Abebe SM, Sisay M. Magnitude and factors associated with adherence to Iron and folic acid supplementation among pregnant women in Aykel town, Northwest Ethiopia. BMC Pregnancy Childbirth. 2019;4:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kavle JA, Landry M. Community-based distribution of iron-folic acid supplementation in low-and middle-income countries: a review of evidence and programme implications. Public Health Nutr. 2017;21(2):346–54. doi: 10.1017/S1368980017002828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Desta M, Kassie B, Chanie H, Mulugeta H, Yirga T, Temesgen H, et al. Adherence of iron and folic acid supplementation and determinants among pregnant women in Ethiopia: a systematic review and meta-analysis. Reprod Heal [Internet]. 2019;16(1). Available from: 10.1186/s12978-019-0848-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Mithra P, Unnikrishnan B, Rekha T, Nithin K, Mohan K. Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India. 2014;14(1):255–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Nwaru BI, Salomé G, Abacassamo F, Augusto O, Cliff J, Sousa C, et al. Adherence in a pragmatic randomized controlled trial on prophylactic iron supplementation during pregnancy in Maputo, Mozambique. 2014;18(6):1127–34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Getachew M, Abay M, Zelalem H, Gebremedhin T, Grum T. Magnitude and factors associated with adherence to Iron-folic acid supplementation among pregnant women in Eritrean refugee camps, northern Ethiopia. BMC Pregnancy Childbirth. 2018;18(1):1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Demis A, Geda B, Alemayehu T, Abebe H. Iron and folic acid supplementation adherence among pregnant women attending antenatal care in North Wollo Zone northern Ethiopia : institution based cross ‑ sectional study. BMC Res Notes [Internet]. 2019;1–7. Available from: 10.1186/s13104-019-4142-2 doi: 10.1186/s13104-019-4142-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kassa ZY, Awraris T, Daba AK, Tenaw Z. Compliance with iron folic acid and associated factors among pregnant women through pill count in Hawassa city, South Ethiopia : a community based cross- sectional study. Reprod Heal. 2019;16(1):10–7. doi: 10.1186/s12978-019-0679-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gebremedhin S, Samuel A, Mamo G, Moges T, Assefa T. Coverage, compliance and factors associated with utilization of iron supplementation during pregnancy in eight rural districts of Ethiopia : a cross-sectional study. BMC Public Health [Internet]. 2014;1–8. Available from: https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-607 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lyoba WB, Mwakatoga JD, Festo C, Mrema J, Elisaria E. Adherence to Iron-Folic Acid Supplementation and Associated Factors among Pregnant Women in Kasulu Communities in North-Western Tanzania. Int J Reprod Med [Internet]. 2020; Available from: 10.1155/2020/3127245 doi: 10.1155/2020/3127245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.CSA. Summary and Statistical Report of the 2007 Population and Housing Census Results [Internet]. Addis Ababa, Ethiopia; 2008. [cited 2014 Sep 30]. Available from: https://www.ethiopianreview.com/pdf/001/Cen2007_firstdraft[1].pdf [Google Scholar]
  • 17.FMOH. Federal Democratic Republic of Ethiopia Ministry of Health: Health and Health Related Indicator [Internet]. Addis Ababa, Ethiopia: Ministry of Health; 2017. Available from: http://www.repository.iifphc.org/bitstream/handle/123456789/395/Health and Health Related Indicator 2017.pdf?sequence = 1&isAllowed = y [Google Scholar]
  • 18.Gebremichael TG, Welesamuel TG. Adherence to iron-folic acid supplement and associated factors among antenatal care attending pregnant mothers in governmental health institutions of Adwa town, Tigray, Ethiopia: Cross-sectional study. PLoS One. 2020;15(1):1–11. doi: 10.1371/journal.pone.0227090 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nasir BB, Fentie AM, Adisu MK. Adherence to iron and folic acid supplementation and prevalence of anemia among pregnant women attending antenatal care clinic at Tikur Anbessa Specialized. 2020;1–11. Available from: 10.1371/journal.pone.0232625 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Seifu CN, Whiting SJ, Getachew T. Better-Educated, Older, or Unmarried Pregnant Women Comply Less with Iron–Folic Acid Supplementation in Southern Ethiopia. J Diet Suppl [Internet]. 2019;0(0):1–12. Available from: 10.1080/19390211.2019.1629145 doi: 10.1080/19390211.2019.1629145 [DOI] [PubMed] [Google Scholar]
  • 21.Sadore AA, Gebretsadik LA, Hussen MA. Compliance with Iron-Folate Supplement and Associated Factors among Antenatal Care Attendant Mothers in Misha District, South Ethiopia : Community Based Cross-Sectional Study. 2015;2015:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.CSA. Ethiopia Demographic and Health Survey 2016:Central Statistical Agency(CSA) Addis Ababa, Ethiopia [Internet]. The DHS Program ICF Rockville, Maryland, USA; 2017. Available from: https://dhsprogram.com/pubs/pdf/FR328/FR328.pdf. [Google Scholar]
  • 23.Dadi TL, Medhin G, Kasaye HK, Kassie GM, Jebena MG, Gobezie WA, et al. Continuum of maternity care among rural women in Ethiopia : does place and frequency of antenatal care visit matter ? Reprod Health. 2021;18(220):1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Keats EC, Haider BA, Tam E, Bhutta ZA. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;2019(3). doi: 10.1002/14651858.CD004905.pub6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Chmielewska A, Dziechciarz P, Gieruszczak-Białek D, Horvath A, Pieścik-Lech M, Ruszczyński M, et al. Effects of prenatal and/or postnatal supplementation with iron, PUFA or folic acid on neurodevelopment: update. Br J Nutr [Internet]. 2019;122((s1)):S10–s5. Available from: 10.1017/S0007114514004243 doi: 10.1017/S0007114514004243 [DOI] [PubMed] [Google Scholar]
  • 26.Fouelifack FY, Sama JD and, Sone CE. Assessment of adherence to iron supplementation among pregnant women in the Yaounde gynaeco-obstetric and paediatric hospital. Pan Afr Med J. 2019;8688:1–8. doi: 10.11604/pamj.2019.34.211.16446 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ba DM, Ssentongo P, Kjerulff KH, Na M, Liu G, Gao X, et al. Adherence to Iron Supplementation in 22 Sub-Saharan African Countries and Associated Factors among Pregnant Women : A Large Population-Based Study. 2019;1–8. doi: 10.1093/cdn/nzz120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mugo NS, Mya KS, Raynes- C. Country compliance with WHO- ­ recommended antenatal care guidelines : equity analysis of the 2015–2016 Demography and Health Survey in Myanmar. BMJ Glob Heal. 2020;1–14. doi: 10.1136/bmjgh-2019-002169 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Mithra P, Unnikrishnan B, Rekha T, Nithin K, Mohan K, Kulkarni V, et al. Compliance with iron-folic acid (IFA) therapy among pregnant women in an urban area of south India. 2013;13(4):6–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Moshi FV, Millanzi WC, Mwampagatwa I. Factors Associated With Uptake of Iron Supplement During Pregnancy Among Women of Reproductive Age in Tanzania: an Analysis of Data From the 2015 to 2016 Tanzania Demographic and Health Survey and Malaria Indicators Survey. Front Public Heal. 2021;9(July):1–8. doi: 10.3389/fpubh.2021.604058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Tsegaye B, Ayalew M. Prevalence and factors associated with antenatal care utilization in Ethiopia: an evidence from demographic health survey 2016. BMC Pregnancy Childbirth [Internet]. 2020;20(528). Available from: 10.1186/s12884-020-03236-9 doi: 10.1186/s12884-020-03236-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Guo F, Xiong H, Qi X, Takesue R, Zou BM S, He PhD Q, et al. Maternal Health-Seeking Behavior and Associated Factors in the Democratic Republic of the Congo. Heal Educ Behav [Internet]. 2021. Oct 1 [cited 2022 Jun 10];48(5):700–9. Available from: https://journals.sagepub.com/doi/10.1177/10901981211010438?url_ver = Z39.88-2003&rfr_id = ori%3Arid%3Acrossref.org&rfr_dat = cr_pub++0pubmed doi: 10.1177/10901981211010438 [DOI] [PubMed] [Google Scholar]
  • 33.Donahoe JT, McGuire TG. The vexing relationship between socioeconomic status and health. Isr J Health Policy Res. 2020;9(1):1–3. doi: 10.1186/s13584-020-00430-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Linglin Xie

24 May 2022

PONE-D-22-06567Time to non-adherence of iron folic acid supplementation and associated factors among pregnant women in hosanna town, South Ethiopia: Cox-proportional hazard model.PLOS ONE

Dear Dr. Bancha,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by 7/23/2022. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Linglin Xie

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. You indicated that you had ethical approval for your study. In your Methods section, please ensure you have also stated whether you obtained consent from parents or guardians of the minors included in the study or whether the research ethics committee or IRB specifically waived the need for their consent

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript needs details descriptions on certain areas, and a thorough grammatical checks. It has potential to be published if the details can be incorporated especially in the methods and results sections. I have additional comments as follows:

Title

Suggest changing title to describe clearly it is iron and folic acid. Current title is rather misleading especially the phrasing of “iron folic acid”

Abstract

- Background could highlights the supplementation nonadherence issues in association to poor pregnancy outcomes

- could be better described in terms of brief methods used/factors assessed

- use of abbreviation in conclusion when it wasn’t introduced previously anywhere in manuscript should be avoided

Introduction

- line 67-70: does this definition in reference to also Ethiopian government?

- line 73: gap of evidences was not discussed, vaguely stated – as in what was being carried out previously in reference to non-adherence and the associated factors, so the need of the study was not clearly justified

- also, tenses in general needs re checking

Methods

- suggest revising the description of setting to a more relevant information pertaining location

- population was not clearly described, especially on the inclusion including age range, trimesters

- line 88-90: not clear on which pregnant women were included in the study

- suggest changing the use of word kebele for comprehension of wider audience

- multisampling can be better visualised with use of flowcharts – suggest to include 1

- line 118-121: vaguely described the tools used – detailed explanation required

- operational definitions – arrangement of this information is out of place, with no references to which definitions were referred to

- data QA was carried out, but all the information provided were not described as part of the tools used, so this information makes no sense

- data analyses were described in details, however it was difficult to follow when tools used/factors assessed were not adequately described

Results

- line 179 suggest to remove under the study

- line 181 missing %

- readers could understand better of wealth index status if this was described in methods clearly

- figure 1 - and 2 – wrongly spelled education, labelled incorrectly in terms of numbers, and don’t see the need for including the histogram on reasons why women skipped supplementation when this could be presented in just tables

- maternal characteristics can be described under study population background

- results were not described adequately before the presentation of findings from analyses eg; descriptive of each of the factors

Discussion

- line 255- 259 were repetitions from previous sections – suggest to remove

- line 259 suggest to replace word “witnessed”

- line 261: median time was first mentioned in discussion not in results where it should be clearly presented as this would be the primary outcome?

- should include wide range of supporting literatures, and include the mechanism explanation to reason the findings observed

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Sep 23;17(9):e0275086. doi: 10.1371/journal.pone.0275086.r002

Author response to Decision Letter 0


8 Jul 2022

Dear Reviewers, it is our great pleasure to mention that your comments and corrections are very valuable for further progress to this paper. Following, we are mentioning some important responses and amendments as per comments and adhering to the journal guideline

• Iron and folic acid supplementation recommendation and definition also holds true in Ethiopian government

• In the manuscript we have mentioned that all pregnant women who booked for ANC one-week prior the study were included and also exclusion mentioned.

• The Administrative structure in Ethiopia includes “kebele” for which we couldn’t find the corresponding English analogue and considering this we mentioned that it is a least administrative structure

• For tools and factors assessed we are supplementing it with the tool we have used in the study.

• We believed that line 229–235 best fits in methods, we've relocated it to the section under the subheading of “Data Processing and Analysis”.

• We have made the data set and tools used available in this version.

• For others we did all the effort to adhere to the journal guideline and recommendations proposed by the authors. The revised version is submitted in with a track change and also without track change. Hope that this revised version will satisfy the journal standard.

Thanks in advance

Decision Letter 1

Linglin Xie

31 Aug 2022

PONE-D-22-06567R1Time to non-adherence to iron and folic acid supplementation and associated factors among pregnant women in Hosanna town, South Ethiopia: Cox-proportional hazard model.PLOS ONE

Dear Dr. Bancha,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 15 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Linglin Xie

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: - Suggestion to be consistent with using the survival time to non-adherence or just tome to non-adherence.

- Was other pregnancy related condition captured in this study such as GDM or history of GDM, hypertension etc? Just wondering whether this could have any effect on adherence.

- What is the exclusion criteria?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Sep 23;17(9):e0275086. doi: 10.1371/journal.pone.0275086.r004

Author response to Decision Letter 1


5 Sep 2022

Dear editor/reviewers,

We acknowledge all the concerns and we took a big lesson during the revision of our manuscript. Following this, here are point by point responses to the concerns. Line number that we are using in this note is based on the revised “manuscript”.

Inconsistent use of terms/phrases: We really appreciate out reviewers’ concern and in the current version we adhered to us “time to non-adherence”.

Data collection tool: We acknowledge our respected reviewers’ concern on GDM hypertension and the likes, but our tool didn’t capture issues related to GDM and hypertension, but it has captured data related to history of adverse fetal outcomes (abortion, still birth, LBW, preterm birth), but these have not shown statistical significance association with our primary outcome both in crude and adjusted model. Data was also collected on reported anemia in the current pregnancy, which has significant association with time to non-adherence in crude analysis but not in adjusted model. We have described these variables under the subheading of “Pregnancy related conditions (line # 231-234) and discussion section (line # 330-331).

Exclusion inclusion: Even though we didn’t state this in as separate subheading, we mentioned excusing and inclusion criteria under the subheading of “Study design and population” (line # 91-95), given that the submission guideline doesn’t recommend separate subheading to this section line.

Tabele1: we made certain corrections in table 1 (e.g. digits, bracket type…)

Citations and referencing:

In accordance to the reviewers' concerns, we searched for more references (#30 and 33) to strengthen the discussion. We evaluated lists of the references in both our first and revised versions of the work, but we were unable to obtain a retracted reference. We learned that the reference #1 in the previous versions was not in PubMed database and we suspected the article is not from indexed publisher; hence we removed it from the list. We used Mendeley Reference Manager to handle our references while revising the text, during which we used various apparatuses (computers). We had to reinstall the reference manager because of some technical issues we encountered throughout this process. This might have caused some alterations to our referencing style. We noticed that some references lacked the URL and name of the journal. We believe that we've fixed the problems with reference and citation in this version.

Supplemental Material: We made a minor correction in fig. 1. Hosanna Town added at the top of the figure. In previous submission, cluster of Jalonaramo was Embeded into Bobicho, and this’s corrected in the current version. Font type was also corrected to Arial.

Thanks for consideration!!

Decision Letter 2

Linglin Xie

12 Sep 2022

Time to non-adherence to iron and folic acid supplementation and associated factors among pregnant women in Hosanna town, South Ethiopia: Cox-proportional hazard model.

PONE-D-22-06567R2

Dear Dr. Bancha,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Linglin Xie

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Linglin Xie

15 Sep 2022

PONE-D-22-06567R2

Time to non-adherence to iron and folic acid supplementation and associated factors among pregnant women in Hosanna town, South Ethiopia: Cox-proportional hazard model.

Dear Dr. Bancha:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Linglin Xie

Academic Editor

PLOS ONE


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES